“We shouldn’t settle for a new normal. We can get back to the old normal,” according to Meissa Vaccines CEO Marty Moore, as he touts his company’s nasal spray Covid-19 vaccine.
Its premise is simple, as explained in a Business Insider report on Oct 28. A nasal mist can stop how this coronavirus has been spread — mainly by people talking, singing, laughing, sneezing and just breathing when they are around other people.
“An intranasal vaccine could help bring an end to the pandemic and help give us true control over SARS-CoV-2 by limiting infection and transmission,” said Mr Moore.
Much more clinical data will be needed before this becomes a reality, but immunologists around the globe are getting excited over the possibility of a nasal spray vaccine — which won’t need a needle stuck in anyone’s arm – returning life to normal.
Such jabs provide systemic immunity to the body, and are designed to protect the lungs, heart, and other internal organs from severe disease, but they don’t do much for the nose, which is most often exposed to the virus. In other words, the nose needs mucosal immunity which jabs don’t really deliver.
US infectious disease specialist Celine Gounder said that we have to “find another way to elicit a mucosal response to complement the systemic immune response”. And that could be the nasal spray vaccine.
.
.
/TISG